| 2.31 -0.06 (-2.53%) | 04-21 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.82  |
1-year : | 3.3 |
| Resists | First : | 2.42 |
Second : | 2.82 |
| Pivot price | 2.17 |
|||
| Supports | First : | 2.09 |
Second : | 1.89 |
| MAs | MA(5) : | 2.32 |
MA(20) : | 2.13 |
| MA(100) : | 2.42  |
MA(250) : | 3.47 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 83.4 |
D(3) : | 86.6 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 5.8 | Low : | 1.76 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GDRX ] has closed below upper band by 23.3%. Bollinger Bands are 19.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.42 - 2.44 | 2.44 - 2.45 |
| Low: | 2.28 - 2.3 | 2.3 - 2.31 |
| Close: | 2.29 - 2.31 | 2.31 - 2.33 |
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Wed, 22 Apr 2026
GoodRx Holdings (GDRX) Sector Leadership | Q4 2025: EPS Misses Estimates - Bond Issuance - Xã Thanh Hà
Fri, 17 Apr 2026
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - Business Wire
Fri, 17 Apr 2026
GDRX News | GOODRX HOLDINGS INC-CLASS A (NASDAQ:GDRX) - ChartMill
Wed, 15 Apr 2026
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
Wed, 15 Apr 2026
GoodRx (GDRX) director Wendy Lynn Barnes converts RSUs and uses 120,456 shares for taxes - Stock Titan
Fri, 03 Apr 2026
Director departs as GoodRx (GDRX) rebalances board classes and terms - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 109 (M) |
| Shares Float | 95 (M) |
| Held by Insiders | 12.5 (%) |
| Held by Institutions | 57.8 (%) |
| Shares Short | 8,690 (K) |
| Shares Short P.Month | 10,940 (K) |
| EPS | 0.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.8 |
| Profit Margin | 3.8 % |
| Operating Margin | 18.9 % |
| Return on Assets (ttm) | 4.7 % |
| Return on Equity (ttm) | 4.5 % |
| Qtrly Rev. Growth | -1.9 % |
| Gross Profit (p.s.) | 6.8 |
| Sales Per Share | 7.33 |
| EBITDA (p.s.) | 1.12 |
| Qtrly Earnings Growth | -9.7 % |
| Operating Cash Flow | 168 (M) |
| Levered Free Cash Flow | 82 (M) |
| PE Ratio | 25.66 |
| PEG Ratio | 0 |
| Price to Book value | 1.27 |
| Price to Sales | 0.31 |
| Price to Cash Flow | 1.49 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|